Guideline Directed Anticoagulant Treatment and Dosing in a Contemporary Atrial Fibrillation Cohort: Analysis of the TRANSECT-AF Program
Within this Canadian AF registry, 11% of patients were on NGDT and 32% of patients on GDT with a DOAC were treated with a guideline-discordant dose. Our analysis describes predictors of guideline discordant anticoagulation and DOAC dosing that may be used to identify target populations for future quality improvement initiatives in AF thromboprophylaxis.
Authors
- Andrew T. Yan (ORCID: https://orcid.org/0000-0002-2063-7485)
- Mary Tan (ORCID: https://orcid.org/0000-0003-0227-9159)
- Michael Heffernan (ORCID: https://orcid.org/0000-0002-9173-2316)
- Jean‐Claude Grégoire (ORCID: https://orcid.org/0000-0002-3346-4130)
- Jeffrey Habert (ORCID: https://orcid.org/0000-0003-0009-3182)
- Sandeep Aggarwal (ORCID: https://orcid.org/0000-0001-6901-7124)
- Shaun G. Goodman (ORCID: https://orcid.org/0000-0001-8068-2440)
- Kevin O. Saunders (ORCID: https://orcid.org/0000-0001-7399-7954)
- Cole Clifford
- Robert Maranda
- Shahin Jaffer (ORCID: https://orcid.org/0000-0002-8321-4842)
- Anil Kumar Gupta (ORCID: https://orcid.org/0000-0002-7524-3635)
- W.H. Chow
Institutions
- Island Health (CA)
- St. Michael's Hospital (CA)
- University Health Network (CA)
- University of British Columbia (CA)
- Vancouver Community College (CA)
- University of Alberta (CA)
- University of Calgary (CA)
- University of Toronto (CA)
- Seven Oaks General Hospital (CA)
- Montreal Heart Institute (CA)
- Trillium Health Centre (CA)
- Canadian VIGOUR Centre (CA)
- Tewkesbury Community Hospital (GB)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Canadian Heart Research Centre (CA)
- HalTech (CA)
- Unity Health Toronto
Publication Details
- Journal
- CJC Open
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1016/j.cjco.2024.12.010
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bayer
- Bayer Canada